Jefferies Recommends Buy Rating for Inspire Medical Systems Stock
Jefferies Commends Inspire Medical’s Solid Fundamentals and Initiates Buy Rating
monsitj Jefferies recently initiated coverage of Inspire Medical Systems (NYSE:INSP) with a buy rating, emphasizing the company’s solid fundamentals and the anticipated minimal impact from GLP-1 drugs. The analysts’ note expressed confidence in strong underlying strength, driven by increasing Hypoglossal Nerve Stimulation (HGNS) penetration and awareness. They cited label expansion, progress in reducing pre-surgery diagnostic ...